<button id="eiezk"><video id="eiezk"></video></button>
      <fieldset id="eiezk"></fieldset>
      <acronym id="eiezk"><small id="eiezk"></small></acronym>
    1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
      <acronym id="eiezk"><address id="eiezk"></address></acronym>
        <source id="eiezk"><pre id="eiezk"></pre></source>

        產(chǎn)品名稱 Human cFGF-21 ELISA Assay Kit from EAGLE BIOSCIENCES INC.
        產(chǎn)品貨號(hào) CTF31-K01
        產(chǎn)品價(jià)格 現(xiàn)貨詢價(jià),電話:010-67529703
        產(chǎn)品規(guī)格 1 x 96 well
        產(chǎn)品品牌 EAGLE BIOSCIENCES INC.
        產(chǎn)品概述
        產(chǎn)品詳情
        Edit&nbsp
        Product NameHuman cFGF-21 ELISA Assay Kit
        DescriptionThis Eagle Biosciences Human C-Terminal ELISA Assay Kit is designed, developed and produced for the quantitative measurement of human C-terminal FGF-21 in serum and EDTA-plasma sample. The assay utilizes the two-site ``sandwich'' technique with two selected antibodies that bind to different epitopes of human FGF-21. One of the antibodies specifically binds to the C-terminal human FGF-21 (175-181) and the other is to the multi-epitopes of mid-regional and N-terminal human FGF-21. Assay calibrators, controls and patient samples are added directly to wells of a microplate that is coated with an anti-human FGF-21 (175-181) specific antibody. After the first incubation period, a horseradish peroxidase-conjugated anti-human FGF-21 polyclonal antibody is added to each well. After the second incubation period, the antibody on the wall of microtiter well captures human C-terminal FGF-21 in the sample and further forms ``sandwich'' with the tracer antibody. Unbound proteins in each microtiter well are washed away. An immunocomplex of ``anti-FGF-21 antibody --- human C-terminal FGF-21 --- HRP-conjugated tracer antibody'' is formed. The unbound tracer antibody is removed in the subsequent washing step. For the detection of this immunocomplex, the well is then incubated with a substrate solution in a timed reaction and then measured in a spectrophotometric microplate reader. The enzymatic activity of the immunocomplex bound to human C-terminal FGF-21 on the wall of the microtiter well is directly proportional to the amount of C-terminal FGF-21 in the sample. A calibrator curve is generated by plotting the absorbance versus the respective human C-terminal FGF-21 concentration for each calibrator on point-to-point or 4 parameter curve fit. The concentration of human C-terminal FGF-21 in test samples is determined directly from this calibrator curve. Sample Types: serum, EDTA plasma. Range: 54 - 2100 pg/mL. Sensitivity: 3.7 pg/mL. Time: 2.5 hours ? Fibroblast Growth Factor 21 (FGF-21) belongs to the FGF-19 subfamily, which includes FGF-19, FGF-21 and FGF-23. The FGF-19 family members are potent endocrine hormones in the regulation of a diverse physiological homeostasis. The intact FGF-21 is a small protein comprising 181 amino acids. Administration of recombinant FGF-21 lowered plasma glucose and insulin levels, reduced hepatic and circulating triglycerides and cholesterol levels, and improved insulin sensitivity, energy expenditure, hepatic steatosis and obesity in a range of insulin-resistant animal models. The physiological functions of FGF-21 are relied on the intact molecular structure and amino acid sequence in its N-terminal and C-terminal region. The C-terminal non-truncated FGF-21 is a potent cell membrane β-Klotho binder. Whereas, a C-terminal truncated FGF-21 (1-170) is a potent inhibitor that competitively inhibits the biological activity of intact FGF-21 (1-181). Therefore, it is important to measure the circulation intact FGF-21 level in the assessment of the physiological and pathophysiological condition. An assay that determines the fragment of the FGF-21 might overestimate the biological activity of the protein in test sample. Circulation FGF-21 is a biomarker and its levels are increased in patients with nonalcoholic fatty liver disease (NAFLD), type 2 diabetes, gestational diabetes and obesity. An increase of circulating FGF-21 is also found in patients with Cushing's syndrome, patients with lipodystrophy induced by HIV-1 and patients with chronic renal disease or end-stage renal disease (ESRD).
        Size1 x 96 well
        Concentrationn/a
        ApplicationsRUO
        Other NamescFGF-21, Fibroblast Growth Factor 21, FGF-21
        Gene, Accession, CAS #n/a
        Catalog #CTF31-K01
        Price
        Order / More InfoHuman cFGF-21 ELISA Assay Kit from EAGLE BIOSCIENCES INC.
        Product Specific Referencesn/a
        產(chǎn)品資料
        <button id="eiezk"><video id="eiezk"></video></button>
            <fieldset id="eiezk"></fieldset>
            <acronym id="eiezk"><small id="eiezk"></small></acronym>
          1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
            <acronym id="eiezk"><address id="eiezk"></address></acronym>
              <source id="eiezk"><pre id="eiezk"></pre></source>

              超碰人人爱人人操,久久女人天堂,18 无套直日本 五月天激情久久,丰满少妇高潮久久久久久,精品人人 国产精品偷窥熟女,日日摸日日添夜夜爽97,欧美一级免费在线视频 | 777视频在线观看,日日干日日草,美女操逼在线看 | 91AV电影,特级黄色小说,亚洲AV无码成人片 | 干屄片,欧美精品一,91精品人妻一区二区三区蜜桃 | 91伊人免费视频在线,男生的鸡鸡桶女生的鸡鸡,亚洲色频 | 国产干屄,嗯啊套套破了h,91福利国产成人精品播放 | 操鸡巴网站,黄色视频一级,精品国产99 | 久久久夜色精品国产6区,漂亮的秘书伦理4,操逼3级黄色毛片儿 | 综合国产,火影裸体无遮挡胸,男人天堂久久久 | 一区二区亚洲,亚洲s欧洲m码一二三,18禁黄暴网站 |